-
Je něco špatně v tomto záznamu ?
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
BA. Hoeben, C. Carrie, B. Timmermann, HC. Mandeville, L. Gandola, K. Dieckmann, M. Ramos Albiac, H. Magelssen, Y. Lassen-Ramshad, B. Ondrová, T. Ajithkumar, C. Alapetite, BV. Balgobind, S. Bolle, AL. Cameron, R. Davila Fajardo, S. Dietzsch, D....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 2000-09-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2000-09-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
- MeSH
- celková dávka radioterapie normy MeSH
- dítě MeSH
- konformní radioterapie normy MeSH
- lidé MeSH
- nádory patologie radioterapie MeSH
- pediatrie normy MeSH
- předškolní dítě MeSH
- radiační onkologie normy MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.
Bristol Haematology and Oncology Centre University Hospitals Bristol NHS Foundation Trust Bristol UK
Danish Centre for Particle Therapy Aarhus University Hospital Aarhus Denmark
Department of Oncology Cambridge University Hospitals Cambridge UK
Department of Oncology Clatterbridge Cancer Centre Liverpool UK
Department of Oncology Oslo University Hospital Oslo Norway
Department of Radiation Oncology Academic Medical Center Amsterdam Netherlands
Department of Radiation Oncology Assistance Publique Hôpitaux de Marseille Marseille France
Department of Radiation Oncology Centre François Baclesse Caen France
Department of Radiation Oncology Centre Léon Bérard Lyon France
Department of Radiation Oncology Ghent University Hospital Ghent Belgium
Department of Radiation Oncology Gustave Roussy Villejuif France
Department of Radiation Oncology Institut Curie Paris and Orsay France
Department of Radiation Oncology Medical Center Hamburg Eppendorf Hamburg Germany
Department of Radiation Oncology Radboud University Medical Center Nijmegen Netherlands
Department of Radiation Oncology Saarland University Hospital Homburg Germany
Department of Radiation Oncology University Medical Center Utrecht Utrecht Netherlands
Department of Radiation Oncology University of Leipzig Leipzig Germany
Department of Radiotherapy Royal Marsden Hospital Sutton UK
Hospital Universitari de la Vall d'Hebron Barcelona Spain
Pediatric Radiotherapy Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
Princess Maxima Center for Pediatric Oncology Utrecht Netherlands
Proton Therapy Center Czech Prague Czech Republic
Proton Therapy Center Santa Chiara Hospital Trento Italy
Radiotherapy Department Istituto Oncologico Veneto IRCCS Padua Italy
Toulouse NeuroImaging Center ToNIC INSERM Université Toulouse 3 Paul Sabatier Toulouse France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022873
- 003
- CZ-PrNML
- 005
- 20201214124920.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1470-2045(19)30034-8 $2 doi
- 035 __
- $a (PubMed)30842059
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hoeben, Bianca A $u Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands. Electronic address: b.hoeben@radboudumc.nl.
- 245 10
- $a Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group / $c BA. Hoeben, C. Carrie, B. Timmermann, HC. Mandeville, L. Gandola, K. Dieckmann, M. Ramos Albiac, H. Magelssen, Y. Lassen-Ramshad, B. Ondrová, T. Ajithkumar, C. Alapetite, BV. Balgobind, S. Bolle, AL. Cameron, R. Davila Fajardo, S. Dietzsch, D. Dumont Lecomte, MM. van den Heuvel-Eibrink, RD. Kortmann, A. Laprie, P. Melchior, L. Padovani, B. Rombi, G. Scarzello, R. Schwarz, K. Seiersen, E. Seravalli, N. Thorp, GA. Whitfield, T. Boterberg, GO. Janssens,
- 520 9_
- $a Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x patologie $x radioterapie $7 D009369
- 650 _2
- $a pediatrie $x normy $7 D010372
- 650 _2
- $a radiační onkologie $x normy $7 D018787
- 650 _2
- $a celková dávka radioterapie $x normy $7 D011879
- 650 _2
- $a konformní radioterapie $x normy $7 D020266
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Carrie, Christian $u Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
- 700 1_
- $a Timmermann, Beate $u Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen, West German Cancer Center, German Cancer Consortium, Essen, Germany.
- 700 1_
- $a Mandeville, Henry C $u Department of Radiotherapy, Royal Marsden Hospital, Sutton, UK.
- 700 1_
- $a Gandola, Lorenza $u Pediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- 700 1_
- $a Dieckmann, Karin $u Department of Radiation Oncology, Universität Klinik für Strahlentherapie und Strahlenbiologie, Vienna, Austria.
- 700 1_
- $a Ramos Albiac, Monica $u Hospital Universitari de la Vall d'Hebron, Barcelona, Spain.
- 700 1_
- $a Magelssen, Henriette $u Department of Oncology, Oslo University Hospital (Norwegian Radium Hospital), Oslo, Norway.
- 700 1_
- $a Lassen-Ramshad, Yasmin $u Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Ondrová, Barbora $u Proton Therapy Center Czech, Prague, Czech Republic.
- 700 1_
- $a Ajithkumar, Thankamma $u Department of Oncology, Cambridge University Hospitals, Cambridge, UK.
- 700 1_
- $a Alapetite, Claire $u Department of Radiation Oncology, Institut Curie, Paris and Orsay, France.
- 700 1_
- $a Balgobind, Brian V $u Department of Radiation Oncology, Academic Medical Center, Amsterdam, Netherlands.
- 700 1_
- $a Bolle, Stephanie $u Department of Radiation Oncology, Gustave Roussy, Villejuif, France.
- 700 1_
- $a Cameron, Alison L $u Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
- 700 1_
- $a Davila Fajardo, Raquel $u Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
- 700 1_
- $a Dietzsch, Stefan $u Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Dumont Lecomte, Delphine $u Department of Radiation Oncology, Centre François Baclesse, Caen, France.
- 700 1_
- $a van den Heuvel-Eibrink, Marry M $u Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
- 700 1_
- $a Kortmann, Rolf D $u Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Laprie, Anne $u Department of Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Toulouse NeuroImaging Center, ToNIC, INSERM Université Toulouse III Paul Sabatier, Toulouse, France.
- 700 1_
- $a Melchior, Patrick $u Department of Radiation Oncology, Saarland University Hospital, Homburg, Germany.
- 700 1_
- $a Padovani, Laetitia $u Department of Radiation Oncology, Assistance Publique Hôpitaux de Marseille, Marseille, France.
- 700 1_
- $a Rombi, Barbara $u Proton Therapy Center, Santa Chiara Hospital, Trento, Italy.
- 700 1_
- $a Scarzello, Giovanni $u Radiotherapy Department, Istituto Oncologico Veneto IRCCS, Padua, Italy.
- 700 1_
- $a Schwarz, Rudolf $u Department of Radiation Oncology, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 700 1_
- $a Seiersen, Klaus $u Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Seravalli, Enrica $u Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
- 700 1_
- $a Thorp, Nicola $u Department of Oncology, Clatterbridge Cancer Centre, Liverpool, UK.
- 700 1_
- $a Whitfield, Gillian A $u Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
- 700 1_
- $a Boterberg, Tom $u Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
- 700 1_
- $a Janssens, Geert O $u Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
- 773 0_
- $w MED00011558 $t The Lancet. Oncology $x 1474-5488 $g Roč. 20, č. 3 (2019), s. e155-e166
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30842059 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214124920 $b ABA008
- 999 __
- $a ok $b bmc $g 1595192 $s 1113549
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 3 $d e155-e166 $e - $i 1474-5488 $m Lancet oncology $n Lancet Oncol. $x MED00011558
- LZP __
- $a Pubmed-20201125
